Aclarion, a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain (cLBP), announced today the product release of Nociscan 2.6 which includes support for additional leading magnetic resonance imaging (MRI) scanners. With this product release, Nociscan can now be performed on MRI machines beyond those manufactured by Siemens.
Dr. Jeffery Lotz is the UCSF researcher whose research Aclarion's technology was founded upon.